Square Root Day

I am from the era when everyone studying higher mathematics owned a slide rule. The first one I owned was made of wood and it tucked away into a stiff green leather case, about a foot long.

When my daughters were young I bought an inexpensive plastic slide rule so I could teach them just what a neat gadget it was. It really had a lot of applications, even if you were using it to draft a pattern for sewing some new item of clothing.

Somehow when the calculators came along that did all those computations I never wanted to give up my slide rule. Maybe it was a trophy of some sort.

Eventually I tucked it away in a drawer. Perhaps today I'll have to take it out, if just for no more than a nostalgic drive.


March 3, 2009
Today is Square Root Day

Slide Rule Cemetary

3/3/09: Math fans to celebrate Square Root Day
REDWOOD CITY, Calif. – Dust off the slide rules and recharge the calculators. Square Root Day is upon us.

The math-buffs' holiday, which only occurs nine times each century, falls on Tuesday — 3/3/09 (for the mathematically challenged, three is the square root of nine).

"These days are like calendar comets, you wait and wait and wait for them, then they brighten up your day — and poof — they're gone," said Ron Gordon, a Redwood City teacher who started a contest meant to get people excited about the event.

The winner gets, of course, $339 for having the biggest Square Root Day event.

Gordon's daughter even set up a Facebook page — one of a half-dozen or so dedicated to the holiday — and hundreds of people had signed up with plans to celebrate in some way. Celebrations are as varied: Some cut root vegetables into squares, others make food in the shape of a square root symbol.

The last such day was five years ago, Feb. 2, 2004, which coincided with Groundhog Day. The next is seven years away, on April 4, 2016.

Copyright © 2009 The Associated Press.

Senator Ortiz y Pino Continues Fight to Ban Aspartame

Please support this important FDA action. And hopefully, this time around, Ajinmoto will not send big checks - like the 10K Bill Richardson accepted - to interfere with fact and the people's will.

New Mexico Senate
Santa Fe, New Mexico
February 12, 2009

The Honorable Frank Torti, M.D.
Acting Commissioner, United States Food and Drug Administration
5400 Fishers Lane
Rockville, Maryland

Dear Dr. Torti:

I am the New Mexico sponsor of the enclosed Senate Memorial 9, 2009, asking the Food and Drug Administration to rescind its approval for the artificial sweetener, aspartame.

You may know that the FDA, to its credit, turned down G.D. Searles application for aspartame's approval from 1966 to 1981, at which point, approval was forced through the FDA at the insistence fo Searles CEO, Donald Rumsfeld.

Numerous physicians petitions as well as many private petitions have been filed with FDA since 1981 asking for the rescinding of aspartames approval. These have all been routinely ignored and responded to with industry assurance about how many industry financed "tests" aspartame has been through, all of which showed "aspartame to be safe."

FDA used to keep records on consumer complaints on aspartame, accruing a minimum of 92 alleged symptoms from ingesting aspartame, ranging from headaches, blurred vision, skin rashes, epilepsy and multiple sclerosis to that ultimate symptom, DEATH.

Dr. Torti, this chemical has produced a massive mountain of medical and neurodengenerative evidence, which I believe would lead you to order it removed from the market. While it is too late to do this now as a "precaution"; it is even more imperative to do this as a means of preventing further medical harm to future victims.

This Memorial is advancing in the New Mexico Senate, after being cosponsored by ten of my colleagues. A similar version of the Memorial has also been introduced by Hawaii Senator Chun Oakland, and is cosponsored by ten members of the Hawaii Senate. That resolution will create an evidentiary repository for Hawaii victims, especially those with diabetes and epileptic seizures, now statistically epidemic in Hawaii, with links to aspartame.

In January 2009, Hawaii Senator Kalani English introduced SB576 in that state. It would ban aspartame entirely in Hawaii. This bill is cosponsored by an astonishing 14 members of the 25 member Hawaii Senate. At the same time, Representative Mele Carroll has introduced HB669, also banning aspartames sale and use in Hawaii.

I realize a permanent FDA Commissioner has not yet been selected by the Obama Administration, but when one is appointed, I will send a similar letter to him/her to again request this action in order to protect the American public from further harm from a chemical that the FDA has known for 43 years is metabolized as methanol, formaldehyde, aspartic acid, phenylalanine, and the proven carcinogen, diketopiperazine.

This regulatory failure of epic proportions entirely resulted from the actions of Donald Rumsfeld when he was with the original patent holder for aspartame. There is sufficient evidence to warrant such a rescinding, a situation not unlike that in 1969 when President Richard Nixon similarly ordered the FDA to take away the approval for another group of carcinogens, cyclamates, which occurred very quickly.

Our concern must be the overarching concerns of preventing further neurodengenerative and carcinogenic damage to hundreds of millions of Americans, who have no other government entity to trust and depend on than the United State Food and Drug Administration!

I believe that President Obama, Congressman Bart Stupak, and Congresswoman Rosa Delauro all want to see the rebuilding of an FDA that merits the restored trust of the American people. I certainly want to see this come about, and I hope you do as well.

Rescinding aspartames FDA approval would be a major credible first step in the right direction.

Sincerely yours,
Gerald Ortiz y Pino
New Mexico State Senator
District 12
Albuquerque

More on health risks of EMF

Quite a few years ago I presented a program to some nurses in Lewiston, Idaho focused on the health impact of EMF and a coming storm of health problems that would be - more likely than not - unable to be diagnosed by mainstream medical providers. Additionally I believed then as I do now that this will be the next rash of health care issues rising, as Dr Rau states, with the addition of DTV, more electric cars and more commercial wind farms ( your stimulus plan), and the many vectors not evaluated for health risk in the long term.

I hope some of the following information will help you to take a better and deeper look at what you may be doing to your health for the sake of convenience.

February 10th, 2009. Dr. Thomas Rau, Medical Director of the world renowned Paracelsus Clinic in Lustmühle, Switzerland says he is convinced ‘electromagnetic loads’ lead to cancer, concentration problems, ADD, tinnitus, migraines, insomnia, arrhythmia, Parkinson’s and even back pain.

One of the most dangerous devices in use, in most homes is the DECT cordless phone. The dangerously high microwave radiation that these 'convenience items' expose families to, are likely to eventually kill and maim more Americans than the two World Wars and the Vietnam war combined. This may take quite some time for the cancer and other illnesses to develop, but scientific research indicates that there is a huge risk of exposing the entire population to this danger and a real cause for deep concern. The adverse health effects of electro magnetic radiation (and in particular microwave radiation) have been known and researched for over sixty years, but it has only been recently that most of the population has been exposed to dangerously high amounts of this pollution. Martin Weatherall

Health Care is Facing a Terrible Dilemma

Here we are with s so-called stimulus plan with some serious detrimental impacts on your health care. Big Pharma has pulled out all the bells and whistles to get their heavily armed (with mega-bucks) lobbyists to fight this war.

So where do you stand?

I'm not sure where the citizen stands if you take a look at how Big Pharma pulled the wool over the eyes of Congress and AARP for the now known to be ruinous Senior Drug Health Plan (Part D). It just looks like it is all going from bad to worse, or to $#%^ in a hand basket.

Perhaps you should peruse the following two articles, think about what it means for you, and let you representatives know exactly what you think.

See Pfizer tips for managing journalists which is certainly a good idea as Pfizer is poised to release its ties to doctors.

Cash-strapped U.S. patients may be skipping drugs
Feb 10, 2009
WASHINGTON (Reuters) – Americans with financial worries because of the ailing economy may be skipping needed prescription drugs in a wrong-headed attempt to save money, according to a survey released on Tuesday.

Nearly 95 percent of doctors surveyed by Epocrates Inc. said they have some concern that patients may not be taking a prescribed drug correctly because of the economic climate.

The biggest concern among the 700 doctors surveyed was that patients were simply not filling prescriptions or skipping doses. The doctors also said they believed some patients were splitting pills.

The healthcare information company said 55 percent of the physicians surveyed said they wrote more prescriptions for generic drugs, which are cheaper than patented drugs, in 2008 than in 2007.

(Reporting by Maggie Fox; Editing by Will Dunham and Eric Walsh)
Copyright © 2009 Reuters Limited

Sobering results for cost-cutting Medicare projectBy LINDSEY TANNER, AP Medical Writer Lindsey Tanner
Feb 10, 2009

CHICAGO – An ambitious effort to cut costs and keep aging, sick Medicare patients out of the hospital mostly didn't work, a government-contracted study found. The disappointing results show how tough it is to manage older patients with chronic diseases, who often take multiple prescriptions, see many different doctors and sometimes get conflicting medical advice.

The study showed just how hard it is to change the habits of older patients and their sometimes inflexible doctors. And it points up the challenges the Obama administration will face in trying to reform health care for an aging nation.

Most of the patients had serious, but common, age-related illnesses including diabetes, heart disease and lung disease. Programs were set up at 15 centers around the country. Only two cut the number of times these patients were hospitalized, and those are still in operation. None saved Medicare any money.

The authors of the study called the results "underwhelming." An editorial in the Journal of the American Medical Association, where the study appears Wednesday, used the term "sobering."

"The only way you can really do it is by changing patients' behavior and by changing physicians' behavior, and both things are really hard to do," said study author Randall Brown, a researcher at Mathematica Policy Research Inc., in Princeton, N.J., which was hired to evaluate the programs.

Often, these patients need to stop smoking, or lose weight, exercise more, eat healthier foods — a challenge even for generally healthy people. Those changes are especially tough for sick, older patients who often are set in their ways.

"The same thing with physicians," Brown said. "A lot of them feel like they know how to take care of patients, so why do they need a nurse calling up and asking them why the patient isn't on some certain medication?"

Many patients in the study had more than one chronic disease, a common Medicare scenario. In 2002 alone, half of Medicare patients had been treated for five or more ailments, and they accounted for 75 percent of Medicare spending, the study authors noted.

Seeking ways to reduce those costs and improve care, the Centers for Medicare & Medicaid Services selected 15 proposals for test-site programs in 2002. The sites developed their own programs, enrolling a total of 18,309 fee-for-service Medicare patients through 2006.

About half got the patients got the usual care. The others got more intensive, coordinated care. That often involved nurses who acted as go-betweens, helping doctors give patients clear, appropriate advice; counseling patients on changing bad habits and recognizing worrisome symptoms. The nurses were available on a regular basis by phone or in person to answer patients' questions.

Jim Reid, a 74-year-old retired Pennsylvania welder, was among study patients who got coordinated care.

When he enrolled in 2002 in a test program run by Health Quality Partners, a nonprofit group in Doylestown, Pa., he was obese, had high blood pressure, high cholesterol and pre-diabetes.

But Reid was a rare success story.

He actually took the advice offered in group sessions run by nurses. He learned how to read food labels and avoid salty, calorie-laden foods. He also started exercising, walking with a pedometer and building up to a few miles daily.

Now, he breakfasts on oatmeal or vegetable omelets instead of coffee and doughnuts He's lost almost 60 pounds. His blood pressure and cholesterol have greatly improved and his pre-diabetes is gone.

Sticking with the program "is hard," he acknowledged. "As you get older, you don't want to do it." But he said it has "put an extra 10 years in my life."

Reid credits his success to the personal attention of a nurse coordinator.

"I have to have somebody to own up to," he said.

That close, in-person contact with nurses was also a feature of the project's other more successful, still-operating program, at Mercy Medical Center-North Iowa in Mason City, Iowa.

In both programs, each patient had face-to-face contact an average of about once a month with a nurse. That was far more frequent personal contact than in other programs. Both reduced hospitalizations — 17 percent yearly compared with usual-care patients at Mercy, and by about 20 percent in the Pennsylvania program, but only among its sicker patients. That program worked with Doylestown Hospital and recruited patients from area physicians' offices.

Targeting sicker patients and providing frequent in-person contact show the approach has some benefits and that success with future reform efforts "is possible, but it's not easy," Brown said.

Peter Ashkenaz, a spokesman for the Centers for Medicare & Medicaid Services, said the agency is evaluating the Iowa and Pennsylvania programs to see if their positive results persist.

He said there are other approaches being tested, some that offer incentives to doctors who meet quality benchmarks, or who use electronic health records to improve quality.

But so far, Ashkenaz said, "as the study shows, we have not yet found broad success."
___

On the Net:
JAMA: http://jama.ama-assn.org
Centers for Medicare & Medicaid Services: http://www.cms.hhs.gov
Copyright © 2009 The Associated Press

FEBRUARY 9, 2009,
Drug Makers Fight Stimulus Provision By ALICIA MUNDY
WASHINGTON -- The drug and medical-device industries are mobilizing to gut a provision in the stimulus bill that would spend $1.1 billion on research comparing medical treatments, portraying it as the first step to government rationing.
The fight over the provision is highlighting the tensions behind President Barack Obama's plan to overhaul the health-care system. The administration hopes to expand coverage while limiting use of treatments that don't work well, but any efforts that might reduce coverage are politically sensitive.

The House version of the stimulus package sent shudders through the drug and medical-device industry. In a staff report describing the bill, the House said treatments found to be less effective and in some cases more expensive "will no longer be prescribed."

A Senate version backed by Finance Committee Chairman Max Baucus (D., Mont.) doesn't mention cost as a subject to be studied. And the industry won a battle to add the word "clinical" in describing the research -- adding to the implication that the comparison studies won't look at bang for the buck. The final language is likely to be hammered out later this week in a House-Senate conference committee.

Mr. Obama is under pressure to find long-run health-cost savings as projections show that Medicare spending is on track to severely deplete the federal budget. "Without question, we're headed for more of a public and private push for which medicines work best at the lowest cost in particular patients," said Mark McClellan, former Medicare and Medicaid chief under President George W. Bush.

The $1.1 billion in research funding would be doled out to the National Institutes of Health and other government bodies. "We should focus on producing the best unbiased science possible," said Rep. Henry Waxman (D., Calif.), a strong proponent of the House language.

Mr. Obama supported research into comparative effectiveness during his campaign. Administration officials and leading Democrats in Congress say the idea will help government programs direct their dollars to treatments that are worth the money.

Officially, drug and device makers don't object to that sentiment. But they warn of a slippery slope where the government ends up axing useful treatments just because they cost too much. They have lined up patient groups that get industry funding to lobby Capitol Hill.

A coalition called the Partnership to Improve Patient Care includes the lobbying arms of the drug, device and biotechnology industries as well as patient-advocacy groups and medical-professional societies. Coalition spokesman David Di Martino says the research envisioned in the House bill may be used "in an inappropriate manner that may limit treatment options for patients."

A public-relations firm that is part of one of Washington's most influential lobby shops, Barbour Griffith Rogers, is representing the coalition. A major goal is to give industry a seat at the table when federal officials decide what to research with the $1.1 billion.

Companies "want to control the data, how it is reviewed, evaluated, and whether the public and government find out about it and use it," said Harry Selker, a Tufts University professor who directs its clinical-research program.

That also worries Jerry Avorn of Harvard Medical School, a frequent drug-industry critic. Comparative research "has the potential to tell us which drugs and treatments are safe, and which ones work," he said. "This is not information that the private sector will generate on its own, or that the industry wants to share."

Michael Cannon of the libertarian Cato Institute said comparative effectiveness research "isn't going to do any good because the industry will defund it as soon as it presents a threat."

When the government's Agency for Health Research Quality suggested in 1995 that there were too many unnecessary back surgeries, doctors and industry groups attacked the conclusion. Mr. Cannon noted that Congress at the time slashed the agency's budget and stripped its authority to make medicare-payment recommendations.

"They almost killed AHRQ," said Dr. Avorn. "The memory of their near-death experience hasn't been forgotten."

Dr. McClellan, the former Medicare chief, said effectiveness research can be useful but shouldn't assume pricey medicines are automatically bad. "The goal isn't to avoid expensive drugs, it's to get more value for our health-care spending," he said.

—Jacob Goldstein contributed to this article.
Alicia Mundy at alicia.mundy@wsj.com
Copyright 2008 Dow Jones & Company, Inc. All Rights Reserved

Green Tea Downside Possible

I am aware that there are many studies supporting the use of ECGC from green tea for cancer and other health concerns.

I am also aware of the many serious side effects of cancer drugs which commonly this information is not provided those patients receiving them. This distresses me more when dealing with recombinant pharmaceuticals known as genetically engineered drugs.

What most people who strongly stand behind the use of green tea do not know is that it has the potential to cause pancreatic cancer.

I am sure the FDA has not tested all the possible interactions between drugs and I am also fairly certain that the same goes for herbal products.

Probably a good study would be to show how herbs and other nutritional approaches to cancer do more good than harm. And how they often offer cure, without long term damaging side effects, when pharmaceuticals do not.

Green tea may block activity of common cancer drug

NEW YORK (Reuters Health) – Some components of green tea may counteract the beneficial effects of a widely used anti-cancer agent called Velcade, also known as bortezomib.

"We know that cancer patients look to green tea extracts among other natural supplements to complement their therapeutic regimens," Dr. Axel Schonthal, said in a statement. "We wanted to better understand how the compounds in green tea interact with a cytotoxic chemical therapy and how that may affect patient outcomes."

In lab studies, Schonthal, from the University of Southern California Keck School of Medicine, Los Angeles, and colleagues evaluated the impact of green tea compounds on the efficacy of bortezomib against multiple myeloma, a blood cancer, and glioblastoma, a malignant brain tumor.

Bortezomib normally fights cancer by inducing tumor cell death. However, Schonthal and colleagues were surprised to find that some of the green tea polyphenols and other components actually prevented bortezomib from killing tumor cells.

"Our surprising results indicate that green tea polyphenols may have the potential to negate the therapeutic efficacy of bortezomib," Schonthal said.

"The current evidence," Schonthal said, "is sufficient enough to strongly urge patients undergoing bortezomib therapy to abstain from consuming green tea products, particularly the widely available, highly concentrated green tea and EGCG (epigallocatechin gallate) products that are sold in liquid or capsule form."

The findings of this study, the investigators emphasize, are specific for patients taking bortezomib as opposed to any other common cancer drug.

"Although the study has exposed detrimental effects of great tea in specific combination with Velcade, this should not minimize the previously reported potentially beneficial effect of this herb," Schonthal said. "Related studies with other types of cancer therapies are promising and green tea extract may actually improve the anticancer effects of other drugs."

SOURCE: Blood, online February 3, 2009.

Spain Serious About Gardasil Risks

This certainly isn't the US approach, but it is probably just a matter of time.

Please parents, pay attention to this newest report about the dangers of Gardasil.

Find more about Gardasil and other risky vaccines via our search window.

Spain withdraws cervical cancer shot after illnessesTue Feb 10, 2009

MADRID (AFP) – Spanish health authorities have withdrawn tens of thousands of doses of a vaccine against cervical cancer after two teenagers who received the shots were hospitalised, regional authorities said on Tuesday.

A batch of nearly 76,000 doses of the human papillomavirus vaccine (HPV) was withdrawn from market, a government statement said, after two girls in the eastern Valencia region fell seriously ill hours after receiving them.

"One of the girls got out of intensive care this weekend and the other is still there. Both are in stable condition," a Valencia health department spokeswoman told AFP.

The two girls were vaccinated last week as part of a vast government vaccination programme targeting adolescents.

The vaccine prevents the most common types of HPV, a common virus spread through sexual contact that can cause cervical cancer.

Some 500,000 cases of cervical cancer are discovered each year, according to United Nations estimates, many in developing countries. If left untreated, invasive cervical cancer is almost always fatal.

Spanish health authorities said in a statement the batch of the Gardasil brand of vaccines was distributed country-wide, with some earmarked for regional vaccination programs and the rest sold at pharmacies.

The vaccine has been available for girls since 2006, ideally before their first sexual encounter.

Sweden recently announced it would offer the vaccines to all primary school girls free of charge as of 2010.

Copyright © 2009 Agence France Presse

Pregnancy and Nutrition

We take a very strong stand against the use of anti-depressants in pregnancy for very good scientific reason. We believe nutrition is the underlying foundation for a healthy pregnancy and a healthy baby.

This of course starts with a healthy mother and a health father.

We believe that birth control pills, fast food, microwaved food, soy-craziness, low fat mania and an overload of over processed foods, fluoridated water and the excessive use of artificial sweeteners contribute to the many problems we see today.
We do support the use of B vitamins during pregnancy (like our biosupplemente naturelle) serve to prevent serious birth defects like Spina Bifida. We also support the use of real food and whole food along with an adequate intake of iodine to protect the mother and the developing fetus.

We believe that low iodine is implicated in post partum maternal health issues and also in the cases of Trisomy 21 or Down Syndrome.

In areas where low selenium levels are present in food, iodine is not sufficiently metabolized.

Since SSRIs' contain fluoride which blocks the uptake of iodine by the thyroid, matters are only worsened. This may be a direct correlation to those cases where a mother has killed her child.

Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring.

Study Abstract: The fetus is the most vulnerable to severe iodine deficiency and hypothyroidism during pregnancy. The effects of mild iodine deficiency and subclinical hypothyroidism are poorly known. The present study assesses the association between thyroid hormones and urinary iodine concentration (UIC) in healthy pregnant women and the birth weight of their children.

Methods: 657 pregnant women were recruited in Sabadell and followed until delivery. The association between thyroid hormones during the first trimester, UIC during the first and third trimesters and birth weight was studied in 557, 251 and 528 mother-newborn pairs, respectively, using linear and logistic regression models adjusted for potential confounders. Only 239 women had all data available (thyroid function and UIC at first and at third trimesters). Six percent of newborns were classified as SGA.

Results: The median UIC was 95mug/L and 104mug/L during the first and third trimesters, respectively. Women with third trimester UICs between 100mug/L and 149mug/L had lower risk of having a SGA newborn than women with UICs below 50mug/L (adjusted OR (95%CI): 0.15 (0.03-0.76). There was no significant reduction in SGA among mothers with higher UICs. Lower free T4 and higher TSH levels during the first trimester were not associated with birth weight or SGA. Nevertheless, analysis were repeated including only those women with all data available, and high TSH levels become statistically significantly associated with lower birth weight and higher risk of SGA.

Conclusions: The present study suggests that iodine status during pregnancy may be related to prenatal growth in healthy women.

Alvarez-Pedrerol M, Guxens M, Mendez M, Canet Y, Martorell R, Espada M, Plana E, Rebagliato M, Sunyer J. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol. 2008 December.
Centre for Research in Environmental Epidemiology, Barcelona, 08003, Spain

.
Related posts from Natural Health News

http://naturalhealthnews.blogspot.com/2008/11/ssri-drugs-in-pregnancy-linked-to-heart.html

http://naturalhealthnews.blogspot.com/2008/05/nutrition-and-preventing-post-partum.html

http://naturalhealthnews.blogspot.com/2008/03/fluoride-is-not-cure-for-mothers-or.html

http://naturalhealthnews.blogspot.com/2006/11/diabetes-epidemic-by-prescription.html

http://naturalhealthnews.blogspot.com/2008/09/birth-control-pill-risk-takes-note-by.html

Patient Consent Update Needed Now

The following two paragraphs come from the January 2008 issue of my newsletter, herbalYODA Says!

"herbalYODA Says! Volume 5, Number 1 – January 2008

The Importance of Informed Consent

Informed consent, according to the University of Washington's School of Medicine, "is the process by which a fully informed patient can participate in choices about his/her health care. It originates from the legal and ethical right the patient has to direct what happens to (their) body and from the ethical duty of the physician to involve the patient in (their) health care."

Informed consent is the cornerstone of ethical conduct in health care. Written consent does not take the place of a patient fully understanding a proposed drug or treatment. Rarely does a person who may have language or illiteracy concerns receive the clarification necessary to understand what it being prescribed or proposed as treatment. (more...)"

I am a staunch supporter of and educator about informed consent. This doctrine is required for any and all medications, treatments, surgeries or tests ordered for you by your health care provider.

The pure reason I am such a stickler is that year after year I find that very little of this process is going on, at least at a level a patient would understand.

The blank stares I get when I ask people about drugs that have been prescribed are telling enough.

The problem, as I see it, is that this is an all too common practice, and a practice that ultimately gets everyone in trouble.

For the very reason that is stated in the title, this article addresses the critical issue, education. I have to agree that is is well past time that not only consent forms, but the consent process come back into vogue.

Patient Consent Forms Should Educate Not Intimidate, Experts Urge
ScienceDaily (Dec. 24, 2008) — It’s time patient consent forms came back full circle to a tool for patient education, rather than the waiver of liability they have become, experts urge.

The original purpose of the consent forms was for a surgeon or doctor to inform the patient of common or serious risks associated with the procedure to be performed. However, the way current consent forms are written – as formal, legal documents – plants a litigious relationship in both the patient’s and the surgeon’s mind even before treatment has begun.

Lawrence Brenner is an attorney on the faculty of the Department of Orthopedics at Yale University. He and his colleagues propose a set of five recommendations to return consent forms to their intended purpose – that of allowing patients to meaningfully take part in the decision-making process. Their suggestions have been published online in Springer’s journal, Clinical Orthopaedics and Related Research.

As surgeons have become increasingly concerned about potential litigation, the informed consent process has lost its educational value. The focus is now on obtaining ‘preoperative release’, rather than an exchange of information to help patients make important decisions about their healthcare choices. In reality, the majority of patients find it a challenge to understand the complicated legal jargon used on the forms.

Research also suggests that proper informed consent has a direct impact on the quality of patients’ recovery after surgery. Indeed, patients have more realistic expectations and are better prepared psychologically to cope with the outcome of the operation when they have had an open discussion with their physician about what to expect during and after surgery.

In order to return informed consent forms to a tool for patient education rather than a form written by lawyers to absolve surgeons from liability, the authors make five recommendations. First, the informed consent form should never be viewed as a substitute for educating the patient; it is merely evidence that an appropriate discussion has taken place. Second, the forms should be designed to be understandable. Third, surgeons should not be afraid to communicate uncertainty in order to have a truly open discussion with their patients. Fourth, patients need to be active participants in the dialogue about the potential risks of the procedure. Finally, a note by the surgeon in the patients’ medical notes, that states that a discussion has taken place, is likely to be much more effective than a lengthy signed, but incomprehensible, form.

--------------------------------------------------------------------------------

Journal reference:

Brenner et al. Beyond Informed Consent: Educating the Patient. Clinical Orthopaedics and Related Research, 2008; DOI: 10.1007/s11999-008-0642-4

Springer (2008, December 24). Patient Consent Forms Should Educate Not Intimidate, Experts Urge.

ScienceDaily: http://www.sciencedaily.com? /releases/2008/12/081217124158.htm

Sniff Your Way to Brain Power

This list of essential oils and their benefit for your brain was something I developed over a decade ago for a class I was teaching for Elders and for use in care centers for people who have been diagnosed with Alzheimer's.

I also taught this in the Corporate Wellness Programs that we sponsor; this program was presented first at Boeing. It has been presented to numerous companies since then.

I searched it out from my old files because of the number of reports recently about peppermint. As I always have suggested, using a diffuser of some type is the best method of dispersal, but you can use something as simple as a cotton ball in a small glass votive holder and place it on your desk at work. Periodically add a few drops of your choice of essential oil, changing the cotton ball when you change your oil selection.

I particularly like to use peppermint as it has such a clean smell. I often add it to the natural cleaning products I make because of the antibacterial benefit.

To help sleep, use lavender and set the holder on your bedside table.

Rosemary is particularly helpful for facilities providing dementia care.

Sniff Your Way to Brain Power -
by the leaflady

Rosemary - helps a weak memory and quickens senses

Lemon - wakes you up

Peppermint - improves work efficiency and dispels drowsiness

Lavender - calming and steadying, helps in decision making

Related Articles:
A Pinch of Spice Helps Keep Drivers Alert

Found on Natural Health News
'Old treatments' better
More to consider surrounding flu
More about happy feet
Better than Rx for GERD
Peppermint takes on a Medical Mask
Keep Your Feet Happy

Estrogen in moisturizers may worsen breast cancer

UPDATE: December 19
This report totally overlooks the effect of these chemicals on women's health. It looks as if all women effected by breast cancer need to write their representatives in Congress, and the EPA.

Hormones Should Be Analyzed Together
Scientists to EPA: Risks of Chemicals That Alter Male Hormones Should Be Analyzed Together Concluding that nearly everybody is exposed to a mix of chemicals that could be damaging male reproductive health, a national panel of scientists on Thursday advised the U.S. Environmental Protection Agency to shift its focus and group them together when judging how much of a danger they pose.

I have referred more than once to the preeminent work of Judi Vance and her 1990s book, "Beauty to Die For". This work began the trail of others that has slowly come forward to report on the very same concerns - there are toxic chemicals in health and beauty products (HABA).

Now the information is coming from the medical establishment.

Even so-called 'natural brands' sold in health stores contain some of these questionable ingredients. And again I encourage you to read labels. Even if the FDA approved a single ingredient they do not test or approve mixtures of ingredients, and this is one place where problems start.

The UV blocking, sun screen type products are also a risk, as most contain endocrine disrupting chemicals.

It is never too late, but perhaps consider all the damage that might have been prevented had people listened to what Judi had to say over 10 years ago.

Another concern is that most of the mass market products act more like a barrier. This continues your purchasing cycle rather than provide you with a product that truly acts to heal dry skin.

The products I have used for a long time now are the result of over twenty years of research and development to achieve real results. If you are looking for organic products I highly recommend Kettle Care.

Breast cancer patients who apply moisturizers may be dosing themselves with estrogen...
By Jill Stein, Reuters - December 15, 2008

SAN ANTONIO (Reuters Health) - Breast cancer patients who apply moisturizers may be dosing themselves with estrogen without even knowing it, investigators reported at a breast cancer symposium in San Antonio.

Dr. Adrienne Olson, with Breastlink in Hawthorne, California, and colleagues analyzed 16 widely available moisturizers for estrogen-like compounds.

None of the creams analyzed noted any estrogen content in their list of ingredients. Even so, six samples contained estriol or estrone.

Olson, who is a seven-year breast cancer survivor, explained that estrogens applied to the skin are more efficiently absorbed into the body than estrogens taken orally.

She urged women with breast cancer that is driven by estrogen (that is, estrogen-receptor positive breast cancer) to avoid externally applied estrogen to minimize the risk of a recurrence.

Women without breast cancer are also at risk, she added. If they use estrogen-containing topical moisturizers, they may be dosing themselves daily with estrogen for extended periods, thereby boosting their risk of breast cancer.

Suzanne M. Snedeker, PhD at Cornell University has a very informative page on estrogens in cosmetics.

Another resource is the Cosmetics Data Base

From My Print Media Series for 12.08, Health Matters©: Natural Notes on Health
Select Recipes Courtesy: StarWest Botanicals
Natural Notes on Health:Winter Skin Care

About 15 years ago I met a woman from Canada that spent over a decade researching the cosmetic industry. She published her book in the early 1990s and subsequently moved because of the number of threats she got because she was exposing this $10 billion industry.

Just in the last few years there are several groups that have raised the issue that Judi Vance first addressed in the 1980s that led to her book, “Beauty to Die For”.

Another friend and colleague of mine has made natural cosmetics now for 25 years. I always sold or recommended her products to my clients and many other people. Her business is now certified organic and she grows many of the herbs and plants that she uses in her products.

Another thing to consider is that even prescription creams, lotions and shampoos for contain a number of ingredients that are untested in combination or may be skin irritants or carcinogenic.

Once it gets colder, drier and windier during the winter months skin takes quite a beating. Probably the most common complaint during these months is dry skin, but it can be prevented with natural products and supplements.

The best way to protect against dry skin is to make sure you have an adequate intake of vitamin A along with vitamins D and E. These are three of the four fat soluble vitamins and this means that you need to ingest healthy fats like butter, olive oil or coconut oil to help the vitamins absorb so they can do their job.

An option you have as well is to make some products on your own.

The good part about making your own natural skin care products is that you control what goes into them and they are free of artificial chemicals. What you make is luxurious and can even be fragrance free.

You reduce waste too because you don’t have to deal with excess packaging.

An easy lip balm can be made as follows:
Please note that most vitamin E capsules are made from synthetic ingredients like GMO soy oil. It is best to use natural vitamin E and this oil is readily available, even in high potency.

If you flavor your lip balm make sure you choose natural flavors as well. Fragrance oils are most often synthetic and made from petroleum and use chemical flavoring.
Use raw or uncooked and unprocessed honey, and olive oil sold in glass bottles. Shea Butter can be used with the bees wax.

2 TBSP olive oil
1/2 tsp. honey
3/4 tsp. beeswax - grated
1/2 tsp. pure cocoa butter
Flavored oil of your choice
1 vitamin E capsule

In a small saucepan, heat oil, honey, wax and cocoa butter over low heat until just melted. Remove from heat and cool for 2-3 minutes. Stir in flavoring and contents of vitamin E capsule. Pour into container.
Anti-aging Dry Skin Moisturizer

4 ounces Shea butter
2 ounces organic olive oil
2 teaspoons organic vitamin E oil, 5000 IU
1 teaspoon active royal jelly
6 drops organic lavender essential oil

Blend ingredients on high until smooth and creamy. Store refrigerated in an airtight container. It is necessary to make this in small amounts and keep refrigerated because of the active royal jelly. This is an awesome ingredient for its healing properties and well worth the effort.

Super Simple Moisturizer
For your hair: Mix one ripe avocado with 2 TBSP raw honey and blend well. Apply to hair for 20-30 minutes, and then wash as usual (you might want to think about using natural hair care products to avoid the chemicals in most shampoos and conditioners).
For your skin: Blend 1/4 cup Aloe vera gel and 2 TBSP vegetable glycerin, of each. You can also add 3 drops of pure essential oil or add 1/2 teaspoon of active royal jelly for anti aging effects.

For your nails: Blend 2 ounces of pure Palma Cristi castor oil with 10 drops of organic lavender essential oil. Massage into nails and cuticles. This also helps reduce or eliminate nail fungus.

I have made my own skin care oil blend for many years using vitamin E oil, rose hips oil and jojoba oil. Rose hips are very high in vitamin C while jojoba oil is good to protect from the effects of aging as is vitamin E. This blend is high in anti-oxidants and lubricates the skin while not being greasy. I find that the fragrance of the oils is very pleasant and I don’t add anything extra.

Jeanne Rose has a wonderful book that I relied on in my hippie days and while raising my children. I suggest it might be available from your library or favorite used book store.

You can order all supplies from the botanical link found on our blog, at www.naturalhealthnews.blogspot.com.

And while a commercial product, I recommend Aura Glow for bath oil or after showering. This is an Edgar Cayce remedy and is available under the Heritage Store brand.

Copyright © 2008 TOC. All rights reserved.

Are Hidden Hormones Destroying Your Health?Health News By VRP Staff
The FDA calls them safe—but you’d be right to think twice.

Synthetic hormones saturate your daily environment—many of them lurking in the meat and milk products you’ve been consuming now for years. And they can come at a very steep price. In fact, if you’re having trouble losing weight, struggling with metabolic syndrome, or battling prostate or breast cancer despite having no family history of the disease, then you may already be paying the price.

The truth is, a lot of today’s modern health crises can be traced back to estrogen. It’s a potent hormone—and its effects can go both ways.

That’s because your body metabolizes estrogen into several different byproducts, including 2-hydroxy, 4-hydroxy, and 16 hydroxy estrogens. Two out of the three—4-hydroxy and 16-hydroxy estrogens—can pose some very serious threats to your health. Research has linked heightened levels of these inflammation-promoting estrogens to breast, cervix and prostate cancers—and to stubborn obesity that can eventually lead to metabolic syndrome and diabetes.1-2

On the contrary, high levels of 2-hydroxy estrogens—or “good estrogens” as they’re sometimes called—have quite the opposite effect, serving to lower telltale PSA levels and protect vulnerable tissue in the prostate, cervix, and breast from cancerous developments.3

Whether the estrogen in your body hurts or helps you is entirely dependent upon how your body uses it—and fortunately, a natural phytonutrient called diindolylmethane (DIM) can ensure that it’s used properly. It’s a potent antioxidant found in cruciferous vegetables, and research shows that it can suppress the macrophage activity that sparks the inflammatory cascade of hormones and cytokines.4-5 It also helps your body to metabolize and remove toxic inflammatory pollutants—thereby reducing these chemicals’ role in disease-promoting inflammation.

Most importantly, DIM has a direct effect on estrogen metabolism, yielding a much higher level of protective 2-hydroxy estrogens.6-7 Not only does this stave off deadly cancerous developments, but it also contributes to weight loss in humans and animals—preventing obesity and metabolic syndrome.8-9 As an added benefit, it also helps to preserve levels of tryptophan, the “feel good” hormone responsible for serotonin production—which is in turn responsible for better moods and appetite control.10-11

DIM is an insoluble indole, meaning that it’s difficult for your body to absorb—but a pure, microencapsulated form of the product insures maximum bioavailablity.12 And that means vital protection against the emerging—and potentially deadly—threat of environmental estrogens.

(High quality DIM products may be ordered from Natural Health News professional partners, with profits going to support this blog and our other avtivities. Please contact us for ordering information or other product information.)
References:

1. Coffey DS. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology. 2001 Apr;57(4 Suppl 1):31-8.

2. Schneider J, Bradlow HL, Strain G, Levin J, Anderson K, Fishman J. Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab. 1983 May;56(5):973-8.

3. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF. Plant-derived 3,3’-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem. 2003 Jun 6;278(23):21136-45.

4. Cho HJ, Seon MR, Lee YM, Kim J, Kim JK, Kim SG, Park JH. 3,3’-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr. 2008 Jan;138(1):17-23.

5. Harman-Boehm I, Blüher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Klöting N, Stumvoll M, Bashan N, Rudich A. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7.

6. Zeligs MA. Diet and estrogen status: the cruciferous connection. J Medicinal Foods. 1998;1:67 82.

7. Dalessandri, KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3’-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer. 2004;50(2):161-7.

8. Ackerman GE, et al., Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives, Endocrinology. 1981;109:2084-8.

9. Zeligs MA. Phytochemicals for promoting weight loss. US Patent #6,534,085, 2003, March.

10. Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player? Curr Drug Metab. 2007 Apr;8(3):289-95.

11. Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli F. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr. 1992 Nov;56(5):863-7.

12. Zeligs MA and Jacobs IC. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals. US Patent #6,086,915. 2000, July.